Progenitor Cell Therapy to Treat Acute Myocardial Infarction: The Promise of High-Dose Autologous CD34(+) Bone Marrow Mononuclear Cells.
about
Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regeneration.Endomyocardial implantation of autologous bone marrow mononuclear cells in advanced ischemic heart failure: a randomized placebo-controlled trial (END-HF).Multipotent (adult) and pluripotent stem cells for heart regeneration: what are the pros and cons?Determinants of clinician adoption of regenerative therapies in the UK and Canada: an ophthalmology perspective.
P2860
Progenitor Cell Therapy to Treat Acute Myocardial Infarction: The Promise of High-Dose Autologous CD34(+) Bone Marrow Mononuclear Cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Progenitor Cell Therapy to Tre ...... Bone Marrow Mononuclear Cells.
@en
type
label
Progenitor Cell Therapy to Tre ...... Bone Marrow Mononuclear Cells.
@en
prefLabel
Progenitor Cell Therapy to Tre ...... Bone Marrow Mononuclear Cells.
@en
P2860
P356
P1476
Progenitor Cell Therapy to Tre ...... Bone Marrow Mononuclear Cells.
@en
P2093
Arshed A Quyyumi
Joseph C Poole
P2860
P304
P356
10.1155/2013/658480
P577
2013-04-28T00:00:00Z